Brief: NewAmsterdam Appoints William H. Lewis as Chair of its Board of Directors
08/01/2024 17:36
Jan 8 (Reuters) - NewAmsterdam Pharma Company NV
KH6.F :
* NEWAMSTERDAM PHARMA APPOINTS WILLIAM H. LEWIS, J.D.,
M.B.A. AS
CHAIR OF ITS BOARD OF DIRECTORS
* NEWAMSTERDAM PHARMA COMPANY NV - LEWIS SUCCEEDS SANDER
SLOOTWEG,
AS CHAIRMAN OF NEWAMSTERDAM'S BOARD OF DIRECTORS
Source text for Eikon: ID:nGNX1ZwLNm
Further company coverage: KH6.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)